Integrated Lung Adenocarcinoma Classification

This international multidisciplinary classification has been produced as a collaborative effort by the International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society. The purpose is to provide an integrated clinical, radiologic, molecular, and pathologic approach to classification of the various types of lung adenocarcinoma that will help to define categories that have distinct clinical, radiologic, molecular, and pathologic characteristics. The goal is to identify prognostic and predictive factors and therapeutic targets.

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe Y., Beer D.G., Powell C.A., Riely G.J., Van Schil P.E., Garg K., Austin J.H., Asamura H., Rusch V.W., Hirsch F.R., Scagliotti G., Mitsudomi T., Huber R.M., Ishikawa Y., Jett J., Sanchez-Cespedes M., Sculier J.P., Takahashi T., Tsuboi M., Vansteenkiste J., Wistuba I., Yang P.C., Aberle D., Brambilla C., Flieder D., Franklin W., Gazdar A., Gould M., Hasleton P., Henderson D., Johnson B., Johnson D., Kerr K., Kuriyama K., Lee J.S., Miller V.A., Petersen I., Roggli V., Rosell R., Saijo N., Thunnissen E., Tsao M, & Yankelewitz D. (2011). International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 6(2), 244-285.

Publication 2011

Adenocarcinoma of the lung Cancer of the lung European Respiratory Therapeutic

Corresponding Organization :

Other organizations : University of Michigan–Ann Arbor, Columbia University, Thoracic Surgery Foundation, University of Antwerp, University of Colorado Boulder, Aichi Cancer Center, Clinica de Pneumologie Iaşi, Pulmonary and Critical Care Associates, Institut d'Investigació Biomédica de Bellvitge, Genesis Foundation, Inserm, Pulmonary Associates, Flinders Medical Centre, Harvard University, National Cancer Center, Taipei Institute of Pathology

Top 5 similar protocols

Protocol cited in 89 other protocols

Variable analysis

independent variables

Not explicitly mentioned

dependent variables

Not explicitly mentioned

control variables

Not explicitly mentioned

controls

The purpose of this multidisciplinary classification is to provide an integrated clinical, radiologic, molecular, and pathologic approach to classification of the various types of lung adenocarcinoma. The goal is to identify prognostic and predictive factors and therapeutic targets, which suggests the use of various controls to ensure valid results. However, the specific controls used are not explicitly mentioned in the input protocol.

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!